ОбзорГрафикНовостиTraderScreen

BVT Knock-Out GNMSF/  DE000VX033D2  /

Frankfurt Zert./VONT
03.06.2024  13:52:46 Изменение-0.030 Бид13:59:43 Предложение13:59:43 Базовый актив Цена исполнения Дата истечения Тип опциона
27.160EUR -0.11% 27.160
Величина цены спроса: 8,000		 27.180
Величина цены предложения: 8,000		 Genmab A/S 3,973.82 DKK 31.12.2078 Put
GlobeNewswire 14:00 ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Sup...
GlobeNewswire 14:00 European Cup Inu: Transforming the Euro 2024 Experience with Innovative Crypto Betting
GlobeNewswire 14:00 Syntec Optics (Nasdaq: OPTX) to Participate in the “Charting the Course: Navigating the Intersection...
GlobeNewswire 14:00 Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fad...
GlobeNewswire 14:00 Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612)...
GlobeNewswire 14:00 VCI Global Gives Full Year Guidance After Seeing Revenues Increase Over 145% in 2023
GlobeNewswire 14:00 LiveOne to Host Special Investor Webcast to Provide Update on Strategic Partnerships, B2B Pipeline a...
GlobeNewswire 14:00 The Metals Company Welcomes Prominent Sustainability Strategist Brendan May to its Board of Director...
GlobeNewswire 14:00 FangDD Announces Termination Plan for Its ADR Facility, and the Plan to Hold an Extraordinary Genera...
GlobeNewswire 14:00 Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-...
GlobeNewswire 14:00 Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyal...
GlobeNewswire 14:00 Abacus Life and AIMCOR Announce New National Distribution Agreement
GlobeNewswire 14:00 Getty Realty Corp. Publishes 2024 Corporate Responsibility Report
GlobeNewswire 14:00 ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet...
GlobeNewswire 14:00 Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Re...
GlobeNewswire 14:00 Replimune Presents Positive Data from RP1 and RP2 Clinical Programs at the 2024 American Society of ...
GlobeNewswire 14:00 DZS Completes NetComm Acquisition
GlobeNewswire 14:00 Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
GlobeNewswire 14:00 KULR Announces Expiration of SEPA Facility and Compliance with NYSE Guidelines on Audit Opinion Disc...
GlobeNewswire 14:00 PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team
GlobeNewswire 14:00 23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-006...
GlobeNewswire 14:00 aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
GlobeNewswire 14:00 Live Oak Bank Announces First Embedded Banking Partnership with Anatomy Financial, Inc.
GlobeNewswire 14:00 Indaptus Therapeutics Announces New Positive Data from Ongoing Phase 1 Trial of Decoy20
GlobeNewswire 14:00 VoIP-Pal Files New Patent Infringement Against Lawsuits Against Verizon, and T-Mobile, Asserting its...